ATP-sensitive K+ channels contribute to the protective effects of exogenous hydrogen sulfide against high glucose-induced injury in H9c2 cardiac cells

Liang,Weijie; Chen,Jingfu; Mo,Liqiu; Ke,Xiao; Zhang,Wenzhu; Zheng,Dongdan; Pan,Wanying; Wu,Shaoyun; Feng,Jianqiang; Song,Mingcai; Liao,Xinxue

doi:10.3892/ijmm.2016.2467

ATP-sensitive K+ channels contribute to the protective effects of exogenous hydrogen sulfide against high glucose-induced injury in H9c2 cardiac cells

Authors:
- Weijie Liang
- Jingfu Chen
- Liqiu Mo
- Xiao Ke
- Wenzhu Zhang
- Dongdan Zheng
- Wanying Pan
- Shaoyun Wu
- Jianqiang Feng
- Mingcai Song
- Xinxue Liao
View Affiliations

Affiliations: Department of Cardiology, Central Hospital of Panyu District, Guangzhou, Guangdong 511400, P.R. China, Department of Cardiac Care Unit, Huangpu Division of The First Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Anesthesiology, Huangpu Division of The First Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Cardiac Catheterization, The First Affiliated Hospital, Sun Yat‑sen University, P.R. China, Department of Cardiology, The First Affiliated Hospital, Sun Yat-sun University, Guangzhou, Guangdong 510080, P.R. China
Published online on: January 25, 2016 https://doi.org/10.3892/ijmm.2016.2467
Pages: 763-772

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hyperglycemia, as well as diabetes mellitus, has been shown to impair ATP-sensitive K+ (KATP) channels in human vascular smooth muscle cells. Hydrogen sulfide (H2S) is also known to be an opener of KATP channels. We previously demonstrated the cardioprotective effects exerted by H2S against high-glucose (HG, 35 mM glucose)-induced injury in H9c2 cardiac cells. As such, we hypothesized that KATP channels play a role in the cardioprotective effects of H2S against HG-induced injury. In this study, to examine this hypothesis, H9c2 cardiac cells were treated with HG for 24 h to establish a model of HG-induced insults. Our findings revealed that treatment of the cells with HG markedly decreased the expression level of KATP channels. However, the decreased expression of KATP channels was reversed by the treatment of the cells with 400 µM sodium hydrogen sulfide (NaHS, a donor of H2S) for 30 min prior to exposure to HG. Additionally, the HG-induced cardiomyocyte injuries, including cytotoxicity, apoptosis, oxidative stress and mitochondrial damage, were ameliorated by treatment with NaHS or 100 µM diazoxide (a mitochondrial KATP channel opener) or 50 µM pinacidil (a non-selective KATP channel opener) for 30 min prior to exposure to HG, as indicated by an increase in cell viability, as well as a decrease in the number of apoptotic cells, the expression of cleaved caspase-3, the generation of reactive oxygen species (ROS) and the dissipation of mitochondrial membrane potential (MMP). Notably, treatment of the H9c2 cardiac cells with 100 µM 5-hydroxydecanoic acid (5-HD, a mitochondrial KATP channel blocker) or 1 mM glibenclamide (Gli, a non-selective KATP channel blocker) for 30 min prior to treatment with NaHS and exposure to HG significantly attenuated the above-mentioned cardioprotective effects exerted by NaHS. Notably, treatment of the cells with 500 µM N-acetyl‑L‑cysteine (NAC, a scavenger of ROS) for 60 min prior to exposure to HG markedly reduced the HG-induced inhibitory effect on the expression of KATP channels. Taken together, our results suggest that KATP channels play an important role in the cardioprotective effects of exogenous H2S against HG-induced injury. This study also provides novel data demonstraring that there is an antagonistic interaction between ROS and KATP channels in HG-exposed H9c2 cardiac cells.

View Figures

View References

1	Wang R: Two's company, three's a crowd: can H₂S be the third endogenous gaseous transmitter? FASEB J. 16:1792–1798. 2002. View Article : Google Scholar : PubMed/NCBI
2	Fiorucci S, Distrutti E, Cirino G and Wallace JL: The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology. 131:259–271. 2006. View Article : Google Scholar : PubMed/NCBI
3	Szabo C: Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 6:917–935. 2007. View Article : Google Scholar : PubMed/NCBI
4	Li L and Moore PK: Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci. 29:84–90. 2008. View Article : Google Scholar : PubMed/NCBI
5	Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, McVie R and Bocchini JA Jr: Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal. 12:1333–1337. 2010. View Article : Google Scholar : PubMed/NCBI
6	Whiteman M, Gooding KM, Whatmore JL, Ball CI, Mawson D, Skinner K, Tooke JE and Shore AC: Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia. 53:1722–1726. 2010. View Article : Google Scholar : PubMed/NCBI
7	Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, Elrod JW, Ramachandran A and Lefer DJ: Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation. 122:11–19. 2010. View Article : Google Scholar : PubMed/NCBI
8	Wang X, Wang Q, Guo W and Zhu YZ: Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection. Biosci Rep. 31:87–98. 2011. View Article : Google Scholar
9	Zhang Y, Tang ZH, Ren Z, Qu SL, Liu MH, Liu LS and Jiang ZS: Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases. Mol Cell Biol. 33:1104–1113. 2013. View Article : Google Scholar : PubMed/NCBI
10	Chen SL, Yang CT, Yang ZL, Guo RX, Meng JL, Cui Y, Lan AP, Chen PX and Feng JQ: Hydrogen sulphide protects H9c2 cells against chemical hypoxia-induced injury. Clin Exp Pharmacol Physiol. 37:316–321. 2010. View Article : Google Scholar
11	Yang Z, Yang C, Xiao L, Liao X, Lan A, Wang X, Guo R, Chen P, Hu C and Feng J: Novel insights into the role of HSP90 in cytoprotection of H₂S against chemical hypoxia-induced injury in H9c2 cardiac myocytes. Int J Mol Med. 28:397–403. 2011.PubMed/NCBI
12	Wang XY, Yang CT, Zheng DD, Mo LQ, Lan AP, Yang ZL, Hu F, Chen PX, Liao XX and Feng JQ: Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress. Mol Cell Biochem. 363:419–426. 2012. View Article : Google Scholar
13	Guo R, Lin J, Xu W, Shen N, Mo L, Zhang C and Feng J: Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells. Int J Mol Med. 31:644–650. 2013.PubMed/NCBI
14	Guo R, Wu K, Chen J, Mo L, Hua X, Zheng D, Chen P, Chen G, Xu W and Feng J: Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NF-κB pathway in H9c2 cardiac cells. Cell Physiol Biochem. 32:1668–1680. 2013.
15	Suzuki K, Olah G, Modis K, Coletta C, Kulp G, Gero D, Szoleczky P, Chang T, Zhou Z, Wu L, et al: Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci USA. 108:13829–13834. 2011. View Article : Google Scholar : PubMed/NCBI
16	Ahmad FU, Sattar MA, Rathore HA, Abdullah MH, Tan S, Abdullah NA and Johns EJ: Exogenous hydrogen sulfide (H₂S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats. Ren Fail. 34:203–210. 2012. View Article : Google Scholar
17	Peake BF, Nicholson CK, Lambert JP, Hood RL, Amin H, Amin S and Calvert JW: Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner. Am J Physiol Heart Circ Physiol. 304:H1215–H1224. 2013. View Article : Google Scholar : PubMed/NCBI
18	Gao Y, Yao X, Zhang Y, Li W, Kang K, Sun L and Sun X: The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats. Int J Cardiol. 152:177–183. 2011. View Article : Google Scholar : PubMed/NCBI
19	Xu W, Wu W, Chen J, Guo R, Lin J, Liao X and Feng J: Exogenous hydrogen sulfide protects H9c2 cardiac cells against high glucose-induced injury by inhibiting the activities of the p38 MAPK and ERK1/2 pathways. Int J Mol Med. 32:917–925. 2013.PubMed/NCBI
20	Zhuang XD, Hu X, Long M, Dong XB, Liu DH and Liao XX: Exogenous hydrogen sulfide alleviates high glucose-induced cardiotoxicity via inhibition of leptin signaling in H9c2 cells. Mol Cell Biochem. 391:147–155. 2014. View Article : Google Scholar : PubMed/NCBI
21	Xu W, Chen J, Lin J, Liu D, Mo L, Pan W, Feng J, Wu W and Zheng D: Exogenous H₂S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways. Int J Mol Med. 35:177–186. 2015.
22	Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J and Tang C: H₂S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun. 313:362–368. 2004. View Article : Google Scholar
23	Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S and Moore PK: Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther. 316:670–678. 2006. View Article : Google Scholar
24	Zhao W, Zhang J, Lu Y and Wang R: The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. 20:6008–6016. 2001. View Article : Google Scholar : PubMed/NCBI
25	Eisen A, Fisman EZ, Rubenfire M, Freimark D, McKechnie R, Tenenbaum A, Motro M and Adler Y: Ischemic preconditioning: nearly two decades of research. A comprehensive review. Atherosclerosis. 172:201–210. 2004. View Article : Google Scholar : PubMed/NCBI
26	Akao M, Ohler A, O'Rourke B and Marban E: Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res. 88:1267–1275. 2001. View Article : Google Scholar : PubMed/NCBI
27	Yamada S, Kane GC, Behfar A, Liu XK, Dyer RB, Faustino RS, Miki T, Seino S and Terzic A: Protection conferred by myocardial ATP-sensitive K⁺ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J Physiol. 577:1053–1065. 2006. View Article : Google Scholar : PubMed/NCBI
28	Zingman LV, Alekseev AE, Hodgson-Zingman DM and Terzic A: ATP-sensitive potassium channels: Metabolic sensing and cardioprotection. J Appl Physiol. 103:1888–1893. 2007. View Article : Google Scholar : PubMed/NCBI
29	Sierra A, Zhu Z, Sapay N, Sharotri V, Kline CF, Luczak ED, Subbotina E, Sivaprasadarao A, Snyder PM, Mohler PJ, et al: Regulation of cardiac ATP-sensitive potassium channel surface expression by calcium/calmodulin-dependent protein kinase II. J Biol Chem. 288:1568–1581. 2013. View Article : Google Scholar :
30	Nichols CG and Lederer WJ: Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol. 261:H1675–H1686. 1991.PubMed/NCBI
31	Noma A: ATP-regulated K⁺ channels in cardiac muscle. Nature. 305:147–148. 1983. View Article : Google Scholar : PubMed/NCBI
32	Garlid KD, Paucek P, Yarov-Yarovoy V, Sun X and Schindler PA: The mitochondrial KATP channel as a receptor for potassium channel openers. Biol Chem. 271:8796–8799. 1996. View Article : Google Scholar
33	Liu Y, Sato T, O'Rourke B and Marban E: Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 97:2463–2469. 1998. View Article : Google Scholar : PubMed/NCBI
34	Findlay I: Interactive regulation of the ATP-sensitive potassium channel of cardiac muscle. J Cardiovasc Pharmacol. 24:S6–S11. 1994.PubMed/NCBI
35	López JR, Ghanbari RA and Terzic A: A KATP channel opener protects cardiomyocytes from Ca₂ waves: a laser confocal microscopy study. Am J Physiol. 270:H1384–H1389. 1996.
36	Grover GJ: Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol. 75:309–315. 1997. View Article : Google Scholar : PubMed/NCBI
37	Holmuhamedov EL, Jovanović S, Dzeja PP, Jovanović A and Terzic A: Mitochondrial ATP-sensitive K⁺ channels modulate cardiac mitochondrial function. Am J Physiol. 275:H1567–H1576. 1998.PubMed/NCBI
38	Yellon DM and Downey JM: Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 83:1113–1151. 2003. View Article : Google Scholar : PubMed/NCBI
39	Gross GJ and Peart JN: KATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol. 285:H921–H930. 2003. View Article : Google Scholar : PubMed/NCBI
40	Weintraub NL: Impaired hypoxic coronary vasodilation and ATP-sensitive potassium channel function: a manifestation of diabetic microangiopathy in humans? Circ Res. 92:127–129. 2003. View Article : Google Scholar : PubMed/NCBI
41	Miura H, Wachtel RE, Loberiza FR Jr, Saito T, Miura M, Nicolosi AC and Gutterman DD: Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res. 92:151–158. 2003. View Article : Google Scholar : PubMed/NCBI
42	Kinoshita H, Azma T, Nakahata K, Iranami H, Kimoto Y, Dojo M, Yuge O and Hatano Y: Inhibitory effect of high concentration of glucose on relaxations to activation of ATP-sensitive K⁺ channels in human omental artery. Arterioscler Thromb Vasc Biol. 24:2290–2295. 2004. View Article : Google Scholar : PubMed/NCBI
43	Kinoshita H, Azma T, Iranami H, Nakahata K, Kimoto Y, Dojo M, Yuge O and Hatano Y: Synthetic peroxisome proliferator-activated receptor-gamma agonists restore impaired vasorelaxation via ATP-sensitive K⁺ channels by high glucose. J Pharmacol Exp Ther. 318:312–318. 2006. View Article : Google Scholar : PubMed/NCBI
44	Seino S and Miki T: Physiological and pathophysiological roles of ATP-sensitive K⁺ channels. Prog Biophys Mol Biol. 81:133–176. 2003. View Article : Google Scholar : PubMed/NCBI
45	Flagg TP, Enkvetchakul D, Koster JC and Nichols CG: Muscle K_ATP channels: recent insights to energy sensing and myoprotection. Physiol Rev. 90:799–829. 2010. View Article : Google Scholar : PubMed/NCBI
46	Zingman LV, Zhu Z, Sierra A, Stepniak E, Burnett CM, Maksymov G, Anderson ME, Coetzee WA and Hodgson-Zingman DM: Exercise-induced expression of cardiac ATP-sensitive potassium channels promotes action potential shortening and energy conservation. J Mol Cell Cardiol. 51:72–81. 2011. View Article : Google Scholar : PubMed/NCBI
47	Zhu Z, Burnett CM, Maksymov G, Stepniak E, Sierra A, Subbotina E, Anderson ME, Coetzee WA, Hodgson-Zingman DM and Zingman LV: Reduction in number of sarcolemmal KATP channels slows cardiac action potential duration shortening under hypoxia. Biochem Biophys Res Commun. 415:637–641. 2011. View Article : Google Scholar : PubMed/NCBI
48	Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, et al: Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 355:467–477. 2006. View Article : Google Scholar : PubMed/NCBI
49	Zhang Y, Han H, Wang J, Wang H, Yang B and Wang Z: Impairment of human ether-à-go-go-related gene (HERG) K⁺ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J Biol Chem. 278:10417–10426. 2003. View Article : Google Scholar : PubMed/NCBI
50	Smogorzewski M, Galfayan V and Massry SG: High glucose concentration causes a rise in [Ca²⁺]i of cardiac myocytes. Kidney Int. 53:1237–1243. 1998. View Article : Google Scholar : PubMed/NCBI
51	Gribble FM and Reimann F: Sulphonylurea action revisited: the post-cloning era. Diabetologia. 46:875–891. 2003. View Article : Google Scholar : PubMed/NCBI
52	Trube G, Rorsman P and Ohno-Shosaku T: Opposite effects of tolbutamide and diazoxide on the ATP-dependent K⁺ channel in mouse pancreatic beta-cells. Pflugers Arch. 407:493–499. 1986. View Article : Google Scholar : PubMed/NCBI
53	Ozcan C, Bienengraeber M, Dzeja PP and Terzic A: Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol. 282:H531–H539. 2002. View Article : Google Scholar : PubMed/NCBI